Site directed spin labeling studies of Escherichia coli dihydroorotate dehydrogenase N-terminal extension

Biochemical and Biophysical Research Communications

Volumn 414, Issue 3, 2011, Pages 487-492

  Couto, Sheila G ^a,b   Cristina Nonato, M ^a   Costa Filho, Antonio J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Dihydroorotate dehydrogenase; Electron spin resonance; Membrane association; Site directed spin labeling; Vesicles

Indexed keywords

DIHYDROOROTATE DEHYDROGENASE; QUINONE DERIVATIVE;

ANISOTROPY; ARTICLE; BINDING SITE; CATALYSIS; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME STRUCTURE; ESCHERICHIA COLI; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SPIN LABELING;

CATALYSIS; ELECTRON SPIN RESONANCE SPECTROSCOPY; ESCHERICHIA COLI; MAGNETIC FIELDS; OROTIC ACID; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROTEIN STRUCTURE, TERTIARY; SPIN LABELS;

ESCHERICHIA COLI; MAMMALIA;

EID: 80054890079     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.092     Document Type: Article

References (32)

1. Bjornberg O., Rowland P., Larsen S., Jensen K.F. Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis. Biochemistry 1997, 36:16197-16205.
2. Fox R.I., Herrmann M.L., Frangou C.G., Wahl G.M., Morris R.E., Strand V., Kirschbaum B.J. Mechanism of action for leflunomide in rheumatoid arthritis. Clin. Immun. 1999, 93:198-208.
3. Williamson R.A., Yea C.M., Robson P.A., Curnock A.P., Gadher S., Hambleton A.B., Woodward K., Bruneau J.M., Hambleton P., Moss D., Thomson T.A., Spinella-Jaegle S., Morand P., Courtin O., Sautés C., Westwood R., Hercend T., Kuo E.A., Ruuth E. Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound. J. Biol. Chem. 1995, 270:22467-22472.
4. Herrmann M.L., Schleyerbach R., Kirschbaum B.J. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Immunopharmacology 2000, 47:273-289.
5. Feliciano P.R., Cordeiro A.T., Costa A.J., Nonato M.C. Cloning, expression, purification, and characterization of Leishmania major dihydroorotate dehydrogenase, Protein. Expression Purif. 2006, 48:98-103.
6. Inaoka D.K., Sakamoto K., Shimizu H., Shiba T., Kurisu G., Nara T., Aoki T., Kita K., Harada S. Structures of trypanosoma cruzi dihydroorotate dehydrogenase complexed with substrates and products: atomic resolution insights into mechanisms of dihydroorotate oxidation and fumarate reduction. Biochemistry 2008, 47:10881-10891.
7. Andersen P.S., Jansen P.J.G., Hammer K. Different dihydroorotate dehydrogenases in Lactococcus lactis. J. Bacteriol. 1994, 176:3975-3982.
8. Karibian D. Dihydroorotate dehydrogenase (Escherichia coli). Methods Enzymol. 1978, 51:58-63.
9. Larsen J.N., Jensen K.F. Nucleotide sequence of the pyrD gene of Escherichia coli and characterization of the flavoprotein dihydroorotate dehydrogenase. Eur. J. Biochem. 1985, 151:59-65.
10. Knecht W., Bergjohann U., Gonski S., Kirschbaum B., Loffler M. Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified enzyme. Eur. J. Biochem. 1996, 240:292-301.
11. Pinheiro M.P., Iulek J., Nonato M.C. Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain. Biochem. Biophys. Res. Commun. 2008, 369:812-817.
12. Norager S., Arent S., Bjornberg O., Ottosen M., Lo Leggio L., Jensen K.F., Larsen S. Lactococcus lactis dihydroorotate dehydrogenase A mutants reveal important facets of the enzymatic function. J. Biol. Chem. 2003, 278:28812-28822.
13. Liu S.P., Neidhardt E.A., Grossman T.H., Ocain T., Clardy J. Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Struct. Fold. Des. 2000, 8:25-33.
14. Hurt D.E., Widom J., Clardy J. Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2006, 62:312-323.
15. Norager S., Jensen K.F., Bjornberg O., Larsen S. E-coli dihydroorotate dehydrogenase reveals structural and functional distinctions between different classes of dihydroorotate dehydrogenases. Structure 2002, 10:1211-1223.
16. Hansen M., Le Nours J., Johansson E., Antal T., Ullrich A., Loffler M., Larsen S. Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain. Protein Sci. 2004, 13:1031-1042.
17. Norager S., Jensen K.F., Bj€ornberg O., Larsen S. Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure 2002, 8:25-33.
18. Couto S.G., Nonato M.C., Costa-Filho A.J. Defects in vesicle core induced by Escherichia coli dihydroorotate dehydrogenase. Biophys. J. 2008, 94:1746-1753.
19. Fanucci G.E., Cafiso D.S. Recent advances and applications of site-directed spin labeling. Curr. Opin. Struct. Biol. 2006, 16:644-653.
20. Altenbach C., Flitsch S.L., Khorana H.G., Hubbell W.L. Structural studies on transmembrane proteins. 2 Spin labeling of bacteriorhodopsin mutants at unique cysteines. Biochemistry 1989, 28:7806-7812.
21. Columbus L., Hubbell W.L. A new spin on protein dynamics. TIBS 2002, 27:288-295.
22. Hubbell W.L., Cafiso D.S., Altenbach C. Identifying conformational changes with site-directed spin labeling. Nat. Struct. Biol. 2000, 7:735-739.
23. Sanger R., Nicklen S., Coulson A.R. DNA Sequencing with Chain-Terminating Inhibitors. Proc. Nat. Acad. Sci. USA 1977, 74:5436-5467.
24. Bjornberg O., Gruner A.C., Roepstorff P., Jensen K.F. The activity of Escherichia coli dihydroorotate dehydrogenase is dependent on a conserved loop identified by sequence homology, mutagenesis, and limited proteolysis. Biochemistry 1999, 38:2899-2908.
25. Schneider D.J., Freed J.H. Calculating slow motional magnetic resonance spectra: a user's guide. Biological Magnetic Resonance 1989, 1-76. Plenum Publishing, New York. L.J. Berliner, J. Reuben (Eds.).
26. Budil D.E., Lee S., Saxena S., Freed J.H. Nonlinear-least squares analysis of slow-motion EPR spectra in one and two dimensions using a modified Levenberg-Marquardt algorithm. J. Magn. Reson. 1996, A120:155-189.
27. Columbus L., Hubbell W.L. Mapping backbone dynamics in solution with site-directed spin labeling: GCN4-58 bZip free and bound to DNA. Biochemistry 2004, 43:7273-7287.
28. Citadini A.P.S., Pinto A.P.A., Araújo A.P.U., Nascimento O.R., Costa-Filho A.J. EPR studies of chlorocatechol 1 2-dioxygenase: Evidences of iron reduction during catalysis and of the binding of amphipatic molecules. Biophys. J. 2005, 88:3502-3508.
29. Ge M.T., Gidwani A., Brown H.A., Holowka D., Baird B., Freed J.F. Ordered and disordered phases coexist in plasma membrane vesicles of RBL-2H3 mast cells. Biophys. J. 2003, 85:1278-1288.
30. Baldwin J., Farajallah A.M., Malmquist N.A., Rathod P.K., Phillips M.A. Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity. J. Biol. Chem. 2002, 277:41827-41834.
31. Malmquist N.A., Baldwin J., Phillips M.A. Detergent-dependent kinetics of truncated plasmodium falciparum dihydroorotate dehydrogenase. J. Biol. Chem. 2007, 282:12678-12686.
32. Mchaourab H.S., Kálai T., Hideg K., Hubbell W.L. Motion of spin-labeled side chains in t4 lysozyme: effect of side chain structure. Biochemistry 1999, 38:2947-2955.